CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.

Revenue
+39.3%
EPS
+1,133.3%
Free cash flow
−68.6%

Quarter to September 2026, against a year earlier

76.96 8.90 −10.37%
Market cap
$4.0B
P/E
30.9×
Fwd P/E
36.2×
Dividend yield
—
F-score
5/9
Altman Z
4.14
Beneish M
−3.36
Dividend safety
n/a

CareDx, Inc. (CDNA) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, CareDx, Inc. (CDNA) trades at a P/S ratio of 8.1×. Over the past ten years it has ranged from 0.4× (April 2017) to 23.1× (January 2021); the current reading is higher than 74% of that period. That is above the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.6× (21.91%)
FY2024 3.4× 47.82%
FY2023 2.3× 24.50%
FY2022 1.8× (77.05%)
FY2021 8.0× (54.25%)
FY2020 17.5× 144.88%
FY2019 7.2× (38.85%)
FY2018 11.7× 243.74%
FY2017 3.4× 264.54%
FY2016 0.9× (65.38%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 6.8× 112.69%
Jun 2026 3.2× 48.87%
Mar 2026 2.2× (18.62%)
Dec 2025 2.6× 23.95%
43 more quarters

Against its own ten years

Low 0.4× High 23.1×
Ten-year median 3.0×
Current reading's percentile 71

P/S ratio against peers

Company P/S ratio
RDNT RadNet, Inc. compare 2.7×
NEO NeoGenomics, Inc. compare 2.7×
VCYT Veracyte, Inc. compare 3.3×
SHC Sotera Health Company compare 3.7×
WGS GeneDx Holdings Corp. compare 4.2×
CDNA CareDx, Inc. 8.1×
BLLN BillionToOne, Inc. compare 12.1×
ADPT Adaptive Biotechnologies Corporation compare 14.5×
GRAL GRAIL, Inc. compare 34.9×
Diagnostics & Research industry median 4.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on CDNA